19:50 EST Aptevo Therapeutics (APVO) trading halted, news pending
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APVO:
- Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
- Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
- Aptevo Therapeutics Announces Promising RAINIER Trial Results
- Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
- Aptevo Therapeutics debuts trispecific antibody candidate APVO451